One-Week Inflammatory Kinetics After First-Line Nivolumab Plus Ipilimumab in Metastatic Renal Cell Carcinoma: A Multicenter Landmark Analysis.
| Publicado en: | Targeted Oncology pp. 1 - 12 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Sep2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=196990165&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 196990165 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17762596 47DQ jtl: Targeted Oncology issn: 17762596 maglogo: N pubinfo: dt: Sep2026 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 196990165 10.1007/s11523-026-01251-y 196990165 ppf: 1 ppct: 11 formats: tig: atl: One-Week Inflammatory Kinetics After First-Line Nivolumab Plus Ipilimumab in Metastatic Renal Cell Carcinoma: A Multicenter Landmark Analysis. aug: au: Inoue, Toru Numakura, Kazuyuki Osawa, Takahiro Naito, Sei Ishihara, Takuma Ohba, Kojiro Ueda, Kosuke Sekine, Yuya Oki, Masaharu Naito, Hirohito Miyata, Haruka Kikuchi, Hiroshi Kobayashi, Shin Narita, Shintaro Tsuchiya, Norihiko Sugimoto, Mikio Igawa, Tsukasa Shin, Toshitaka affil: Department of Urology, Faculty of Medicine, Oita University sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|